|
| ||||||||||||||
Antisoma to present at Merrill Lynch and UBS Global Pharmaceutical Conferences LONDON, UK--(MARKET WIRE)--Sep 16, 2008 -- 16 September 2008, London, UK: Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that it will present at the following Pharmaceutical/Life Sciences conferences. Glyn Edwards, CEO, will present at the Merrill Lynch Global Pharmaceutical Conference in London on 18th September at 09.50 BST. Dr Daniel Elger, Director of Communications, will present at the UBS Global Life Sciences Conference in New York on 23rd September 2008 at 09.00 EDT (14.00 BST). Webcasts of both presentations will be available on Antisoma's website at www.antisoma.com. For live viewing of the webcasts, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.
Background on Antisoma Antisoma is a London Stock Exchange-listed biopharmaceutical company that develops novel products for the treatment of cancer. The Company has operations in the UK and the US. Please visit www.antisoma.com for further information about Antisoma. ---END OF MESSAGE---
Contact: Source: Antisoma plc
|  | |||||||||||||
